2026 Tom van der Poll: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	154	107	101	4	4	1060	126219
Medicine	154	983	904	38	37	1082	126764

Tom van der Poll publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tom van der Poll sits on this spectrum.

62 publications 807+

This scientist: 1,060 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tom van der Poll D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tom van der Poll sits on this spectrum.

40 D-Index 157+

This scientist: 154 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

2026 - Research.com Immunology in Netherlands Leader Award
2025 - Research.com Immunology in Netherlands Leader Award
2023 - Research.com Medicine in Netherlands Leader Award
2022 - Research.com Immunology in Netherlands Leader Award
2019 - Royal Netherlands Academy of Arts and Sciences

Overview

Tom van der Poll is affiliated with the University of Amsterdam in the Netherlands. Their research centers primarily on medicine, with substantial contributions in the fields of immunology and microbiology.

The scientist's work encompasses several subfields including epidemiology, immunology, infectious diseases, molecular biology, and pulmonary and respiratory medicine.

The main topics addressed in their research include:

Sepsis Diagnosis and Treatment
Immune Response and Inflammation
COVID-19 Clinical Research Studies
Respiratory Support and Mechanisms
Pneumonia and Respiratory Infections
Immune cells in cancer
Intensive Care Unit Cognitive Disorders

Recent papers authored or co-authored by van der Poll include:

The immunology of sepsis, 2021, published in Immunity
Pneumonia, 2021, published in Nature Reviews Disease Primers
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity, 2021, published in The Lancet Respiratory Medicine
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity, 2020, published in Science
Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients, 2020, published in American Journal of Respiratory and Critical Care Medicine

Frequent co-authors collaborating with van der Poll include:

W. Joost Wiersinga
Brendon P. Scicluna
Lieuwe D. J. Bos
Marcus J. Schultz
Tom D. Y. Reijnders

Van der Poll has published extensively in several key venues in their field. These include:

American Journal of Respiratory and Critical Care Medicine
Critical Care
Frontiers in Immunology
bioRxiv (Cold Spring Harbor Laboratory)
Intensive Care Medicine

Their contributions have been recognized with an award from the Royal Netherlands Academy of Arts and Sciences in 2019.

Best Publications

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer;Clifford S. Deutschman;Christopher Warren Seymour;Manu Shankar-Hari

29560
Citations
Severe sepsis and septic shock

Derek C. Angus;Tom van der Poll

4804
Citations
The immunopathology of sepsis and potential therapeutic targets

Tom van der Poll;Frank L. van de Veerdonk;Brendon P. Scicluna;Mihai G. Netea

1832
Citations
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

Thomas Vogl;Klaus Tenbrock;Stephan Ludwig;Nadja Leukert

1632
Citations
Mapping the human genetic architecture of COVID-19

Unknown

1594
Citations
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis.

Christopher W. Seymour;Jason N. Kennedy;Shu Wang;Chung-Chou H. Chang

1351
Citations
Bidirectional Relation Between Inflammation and Coagulation

Marcel Levi;Tom van der Poll;Harry R. Büller

1278
Citations
Sepsis: a roadmap for future research

Jonathan Cohen;Jean-Louis Vincent;Neill K J Adhikari;Flavia R Machado

1169
Citations
Inflammation and coagulation.

Marcel Levi;Tom van der Poll

1112
Citations
Pathogenesis, treatment, and prevention of pneumococcal pneumonia.

Tom van der Poll;Steven M Opal

950
Citations
Pneumonia

Unknown

902
Citations
The immunology of sepsis

Tom van der Poll;Manu Shankar-Hari;Manu Shankar-Hari;W. Joost Wiersinga

887
Citations
Coagulation and sepsis

Marcel Levi;Marcel Levi;Tom van der Poll

884
Citations
Inflammation, endothelium, and coagulation in sepsis

Marcel Schouten;Willem Joost Wiersinga;Marcel Levi;Tom van der Poll

867
Citations
Activation of coagulation after administration of tumor necrosis factor to normal subjects.

T van der Poll;H R Büller;H ten Cate;C H Wortel

838
Citations
A guiding map for inflammation

Mihai G Netea;Frances Balkwill;Michel Chonchol;Fabio Cominelli

819
Citations
The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia

Tim J Schuijt;Jacqueline M Lankelma;Brendon P Scicluna;Felipe de Sousa e Melo

812
Citations
Host-pathogen interactions in sepsis.

Tom van der Poll;Steven M Opal

746
Citations
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei

W. Joost Wiersinga;Tom van der Poll;Nicholas J. White;Nicholas J. White;Nicholas P. Day;Nicholas P. Day

743
Citations
Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit.

Cornelis P C de Jager;Paul T L van Wijk;Rejiv B Mathoera;Jacqueline de Jongh-Leuvenink

720
Citations
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney

Jaklien C. Leemans;Geurt Stokman;Nike Claessen;Kasper M. Rouschop

661
Citations
Pathogenesis and Pathophysiology of Pneumococcal Meningitis

Barry B. Mook-Kanamori;Madelijn Geldhoff;Tom van der Poll;Diederik van de Beek

562
Citations
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

M Levi;H ten Cate;K A Bauer;T van der Poll

532
Citations

Frequent Co-Authors

Sandrine Florquin University of Amsterdam

Alex F. de Vos University of Amsterdam

Cornelis van 't Veer University of Amsterdam

Marcus J. Schultz University of Amsterdam

Marcel Levi University of Amsterdam

Joris J. T. H. Roelofs University of Amsterdam

Joost C. M. Meijers University of Amsterdam

Marc J. M. Bonten Utrecht University

René Lutter University of Amsterdam

Peter Speelman University of Amsterdam

External Links

Personal website of Tom van der Poll

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students transition into nursing roles, and several programs cater specifically to this pathway. For example, online accelerated nursing programs for non nurses provide a fast-track option for individuals without prior nursing experience to enter the field.

Getting into nursing programs can sometimes be competitive, but there are options like the easiest absn program to get into that offer a more accessible entry point for aspiring nurses. Similarly, aspiring Licensed Practical Nurses (LPNs) can explore accredited lpn programs easy to get into, which ensure a solid foundation for clinical work in healthcare settings.

For those aiming to advance their credentials further, easy nurse practitioner programs to get into offer a convenient and flexible path to becoming a nurse practitioner, a role that often collaborates closely with immunology specialists in patient care and research.

Exploring these pathways not only enhances your qualifications but also expands career prospects in healthcare, bridging the gap between immunology knowledge and practical patient outcomes.